Short Summary
ITM Isotope Technologies and Johns Hopkins University settled their dispute over U.S. Patent 12,115,233, leading the PTAB to terminate the post‑grant review before institution.
Detailed Summary
In PGR2025-00065, ITM Isotope Technologies Munich SE challenged claims 1‑4 of U.S. Patent No. 12,115,233 B2. Before the Board could institute a trial, the parties executed a settlement agreement that resolved all underlying disputes. The Board, recognizing the early stage of the proceeding and the parties’ desire to avoid unnecessary costs, granted the joint motion to terminate the proceeding and ordered the settlement documents to be treated as confidential business information.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in ITM Isotope Technologies Munich SE vs The Johns Hopkins University et al. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Mercedes-Benz Group AG et al.vsPhelan Group, LLC
Mercedes-Benz and Phelan Group filed a joint motion to terminate IPR2025-00758 after reaching a settlement that resolves all disputes over U.S. Patent 9,908,508.
Google LLC et al.vsMullen Industries LLC
The Director reviewed the PTAB's denial of institution for Samsung's IPR against Mullen Industries' 8,314,547 patent and affirmed the denial. The Director corrected the Board’s statutory interpretation of pre‑AIA §102(b) but upheld the discretionary denial under §314(a).
Empower Clinic Services, LLC. (d/b/a Empower Pharmacy)vsEli Lilly & Co.
The PTAB denied Empower Clinic Services' request for Director Review of the decision denying institution of IPR2025‑01024, which challenges Eli Lilly's patent 9,474,780. The institution remains denied, ending the challenge.
SAP America, Inc. et al.vsValtrus Innovations Ltd.
SAP America petitions the PTAB to invalidate Valtrus’s ’738 patent covering SIP fault‑tolerance methods, asserting obviousness over the Forissier patent. The petition also argues that discretionary denial under §§ 325(d) and 314(a) is improper.
Tesla, Inc.vsIntellectual Ventures II LLC
Tesla challenged the validity of a target recognition patent (6894639) before the PTAB. The Board granted institution, finding that the Petitioner showed a reasonable likelihood of prevailing in challenging at least one claim under § 103 over Barnard. This decision moves the case forward for substantive review on obviousness grounds.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.